Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Clinical Outcomes of Patients With Relapsed/Refractory Fo... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Clinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow- Up
0
Authors
Stephen Schuster
36 more
Stephen Schuster
•
Nathan Fowler
34 more
•
Martin Dreyling
Published
September 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Lymphoma Myeloma & Leukemia
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Neurology
Show all topics
DOI
10.1016/s2152-2650(24)00855-3